Daily1d
Roche receives USFDA clearance with CLIA waiver for cobas liat sexually transmitted infection multiplex assay panels
Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical ...
Metro Times2d
Metro Detroit leads the country in sexually transmitted infections
Metro Detroit has earned the dubious distinction of leading the country with the highest rate of sexually transmitted ...
Rolling Out3d
A new strain of gonorrhea raises health concerns in the US
A new strain of gonorrhea has emerged, causing significant concern among health professionals due to its resistance to traditional treatments. This sexually ...
Pharm Exec4d
FDA Grants 510(k) Clearance to Roche’s Cobas Liat Molecular Test for Sexually Transmitted Infections
The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...